RetinalGenix Technologies Inc. (RTGN)

USD 53.0

(88.0%)

Gross Profit Summary of RetinalGenix Technologies Inc.

  • RetinalGenix Technologies Inc.'s latest annual gross profit in 2023 was -100.00 USD , down -96.08% from previous year.
  • RetinalGenix Technologies Inc.'s latest quarterly gross profit in 2024 Q2 was -25.00 USD , down 0.0% from previous quarter.
  • RetinalGenix Technologies Inc. reported a annual gross profit of -51.00 USD in annual gross profit 2022, down 0.0% from previous year.
  • RetinalGenix Technologies Inc. reported a annual gross profit of - USD in annual gross profit 2021, down 0.0% from previous year.
  • RetinalGenix Technologies Inc. reported a quarterly gross profit of -25.00 USD for 2024 Q2, down 0.0% from previous quarter.
  • RetinalGenix Technologies Inc. reported a quarterly gross profit of -100.00 USD for 2023 FY, down -96.08% from previous quarter.

Annual Gross Profit Chart of RetinalGenix Technologies Inc. (2023 - 2018)

Historical Annual Gross Profit of RetinalGenix Technologies Inc. (2023 - 2018)

Year Gross Profit Gross Profit Growth
2023 -100.00 USD -96.08%
2022 -51.00 USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%

Peer Gross Profit Comparison of RetinalGenix Technologies Inc.

Name Gross Profit Gross Profit Difference
Acutus Medical, Inc. -3.13 Million USD 99.997%
Biotricity, Inc. 8.35 Million USD 100.001%
Cell MedX Corp. - USD Infinity%
Dynatronics Corporation 7.63 Million USD 100.001%
Nemaura Medical Inc. -1.47 Million USD 99.993%
PetVivo Holdings, Inc. 739.52 Thousand USD 100.014%
Sonendo, Inc. 10.72 Million USD 100.001%
Telesis Bio, Inc. 16.95 Million USD 100.001%
Talis Biomedical Corporation 371 Thousand USD 100.027%
Viveve Medical, Inc. 620 Thousand USD 100.016%